Articles related to SUICIDE

A single 25-mg dose of synthetic psilocybin with structured psychological support produced rapid, large-magnitude reductions in suicidal ideation through 12 weeks in 20 treatment-resistant adults with major depressive disorder, with two participants experiencing worsening ideation.

Adjunctive cognitive behavioral therapy reduced depressive symptoms and ideation scores versus treatment as usual in a 93-patient feasibility trial of esketamine for major depression with suicidal ideation.

Consumer-facing guidance from Verywell Mind highlights how depression in adults over 60 frequently manifests as somatic complaints, cognitive changes, and social withdrawal rather than overt mood symptoms.

“Additional research is needed to determine whether the modest elevations in suicidal behavior observed during treatment are due to true medication effects or to persistence in the distress that prompted treatment initiation.” — Study authors, Biological Psychiatry Global Open Science

“The lived experience of youth who identify as TGD cannot be ignored and the belief that all youth have the inherent right to mental health care — regardless of gender or gender-identity — is reaffirmed.”

“The prevalence of internalizing problems increased more rapidly among Canadians who used cannabis compared to those who do not.” — Study authors